Calidi Biotherapeutics, Inc, a San Diego, CA-based clinical stage Immuno-oncology Company at the forefront of cell-based oncolytic virus immunotherapies for cancer, raised a Series A funding round of undisclosed amount Backers included Korean firms...
READ MORE